COSM

Cosmos Health Inc.

COSM.US cosmoshealthinc.com + Research + Basket
CIK 0001474167
Employees 163
Phone 312 536 3102
Fiscal year end December
IPO Oct 11, 2012
Address 5 Agiou Georgiou Str, Pilea, Thessaloniki, Greece, 55438
0.28
+0.03 (+11.45%)
USD · NASDAQ
52-week range
0.16
0.95
Trading at 15% of the 52-week range
Market Cap
25.06M
P/E Ratio
0.00
Forward P/E
3.37
Book Value
0.26
Div. Yield
N/A
% Institutions
3.68%
% Insiders
23.87%

1 Year

-70.0%

3 Year

-73.1%

10 Year

-99.8%
Description

Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, the United Arab Emirates, Albania, North Macedonia, and Cyprus. The company provides prescription medications, over-the-counter drugs, medical devices, food supplements, nutraceuticals, cosmetics and other healthcare products under the Sky Premium Life and Mediterranation brand names. It offers ASTO-CHOL (Pravastatin), Diorium (Omeprazole), HEART-FREE (Clopidogrel), LIPICHOL (Atorvastatin), Miltus (Donepezil), Newzypra (Olanzapine), PNEUMO-KAST (Montelukast), Sahar (Pioglitazone), VIVALCID (Leucovorin), and Diabit-is (Sitagliptin). In addition, the company offers branded biocides and antiseptic soaps under the C-Sept and C-Scrub brand names; and other pharmaceutical products include Melatonin Spray, used to reduce insomnia and jet lag; Otikon ear drops, which is a Class II medical device in the form of ear drops; and baby foods, such as organic powder milk, pasta with minced meat, whole grain rice cereals, whole grain cereal porridges, and organic rice creams with vanilla milk, as well as pear, carrot and banana purée under the Bio-bebe brand. It serves wholesalers and retail healthcare providers. The company was founded in 2009 and is headquartered in Thessaloniki, Greece.

Actions

Add an action for COSM.US, or sign in to see your action list.

People

▼

Directors & Officers

Name Title Year Born
Mr. Grigorios Siokas Chairman & CEO 1965
Mr. Georgios Terzis Chief Financial Officer 1983
Mr. Nikolaos Bardakis Chief Operating Officer 1969
Mr. Demetrios G. Demetriades Secretary & Independent Director 1965
Prof. Dimitrios Trafalis Head of Oncology NA

Insider Trading

Open insider trading
Date Insider Name Title Transaction Type Shares Price Value SEC
Feb 12, 2026 Grigorios Siokas N/A Purchase 388.53K $0.37 $143.76K SEC
Feb 11, 2026 Grigorios Siokas N/A Purchase 291.26K $0.41 $119.42K SEC
Jan 23, 2026 Grigorios Siokas N/A Purchase 90.33K $0.50 $45.16K SEC
Jan 20, 2026 Grigorios Siokas N/A Purchase 353.32K $0.50 $176.66K SEC
Jan 14, 2026 Grigorios Siokas N/A Purchase 493.50K $0.45 $222.07K SEC
Jan 12, 2026 Grigorios Siokas N/A Purchase 113.19K $0.50 $56.59K SEC
Jan 08, 2026 Grigorios Siokas N/A Purchase 156.19K $0.52 $81.22K SEC
Jan 07, 2026 Grigorios Siokas N/A Purchase 124.88K $0.52 $64.94K SEC
Jan 06, 2026 Grigorios Siokas N/A Purchase 133.95K $0.54 $72.33K SEC
Dec 19, 2025 Grigorios Siokas N/A Purchase 88.31K $0.49 $43.27K SEC
Dec 15, 2025 Grigorios Siokas N/A Purchase 168.47K $0.42 $70.76K SEC
Nov 28, 2025 Grigorios Siokas N/A Purchase 76.36K $0.64 $48.87K SEC
Nov 25, 2025 Grigorios Siokas N/A Purchase 55.73K $0.63 $35.11K SEC
Nov 21, 2025 Grigorios Siokas N/A Purchase 56.08K $0.68 $38.13K SEC
Nov 20, 2025 Grigorios Siokas N/A Purchase 51.32K $0.62 $31.82K SEC
Nov 19, 2025 Grigorios Siokas N/A Purchase 61.61K $0.65 $40.05K SEC
May 23, 2025 Grigorios Siokas N/A Purchase 34.00K $0.45 $15.30K SEC
May 22, 2025 Grigorios Siokas N/A Purchase 141.83K $0.44 $62.40K SEC
May 21, 2025 Grigorios Siokas N/A Purchase 174.17K $0.47 $81.86K SEC
May 20, 2025 Grigorios Siokas N/A Purchase 147.56K $0.45 $66.40K SEC

Shareholders

▼

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
UBS Group AG 594.46K Jun 30, 2026 0.59% $0.00 4,568.31%
Vanguard Fiduciary Trust Co 333.84K Jun 30, 2026 0.33% $0.00 248.71%
Jane Street Group LLC 289.29K Jun 30, 2026 0.29% $0.00 0.00%
Geode Capital Management, LLC 282.09K Jun 30, 2026 0.28% $0.00 -11.32%
BlackRock Inc 267.80K Jun 30, 2026 0.27% $0.00 0.00%
Vanguard Capital Management, LLC 173.97K Jun 30, 2026 0.17% $0.00 24.26%
Northern Trust Corp 53.89K Jun 30, 2026 0.05% $0.00 162.17%
State Street Corp 45.24K Jun 30, 2026 0.05% $0.00 0.00%
Sassicaia Capital Advisers LLC 36.00K Jun 30, 2026 0.04% $0.00 0.00%
KESTRA PRIVATE WEALTH SERVICES, LLC 13.00K Jun 30, 2026 0.01% $0.00 0.00%
Park Capital Management, LLC / WI 12.00K Sep 30, 2026 0.01% $0.00 0.00%
SIMPLEX TRADING, LLC 7.14K Jun 30, 2026 0.01% $0.00 87.69%
NATIONAL BANK OF CANADA /FI/ 6.36K Jun 30, 2026 0.01% $0.00 0.00%
Group One Trading, LLC 1.70K Jun 30, 2026 0.00% $0.00 -28.36%
Hanson Mcclain Inc 1.24K Jun 30, 2026 0.00% $0.00 0.00%
Tower Research Capital LLC 753.00 Jun 30, 2026 0.00% $0.00 -0.26%
SBI Securities Co Ltd 299.00 Jun 30, 2026 0.00% $0.00 166.96%
Citigroup Inc 43.00 Jun 30, 2026 0.00% $0.00 -95.66%
Wells Fargo & Co 40.00 Jun 30, 2026 0.00% $0.00 0.00%
Valley National Advisers Inc 5.00 Jun 30, 2026 0.00% $0.00 0.00%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Fidelity Extended Market Index 274.93K 0.27% ▲ 27.09% Aug 31, 2026
2 Fidelity Series Total Market Index 28.54K 0.03% ▲ 0.00% Aug 31, 2026
3 Fidelity Total Market Index 21.66K 0.02% ▲ 0.00% Aug 31, 2026

Financial Highlights

▼
Market Cap: $25.06M
EBITDA: $-16.79M
PEG Ratio: $0.00
Book Value: $0.26
Earnings/Share: $-0.69
Profit Margin: -33.08%
Operating Margin: -15.41%
ROA (TTM): -18.42%
ROE (TTM): -104.00%
Revenue (TTM): $73.73M
Revenue/Share (TTM): $1.70
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 28.80%

Valuation Metrics

Enterprise Value: $37.90M
Trailing P/E: 0.00
Forward P/E: 3.37

Shares Statistics

Shares Outstanding: 100.63M
Shares Float: 76.58M
% Insiders: 23.87%
% Institutions: 3.68%
Short % Float: 2.67%

Stock Price History

▼

1 Year Price History

3 Years Price History

10 Years Price History

Max Price History

Financial Charts

▼
Open balance sheet Open capital intensity Download Financials (Excel)

Revenue, Net Income & Operating Cash Flow (Yearly)

Change % vs Prior Year

Revenue, Net Income & Operating Cash Flow (Quarterly)

Change % vs Prior Quarter

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

▼
Open full waterfall Open balance sheet
Line Item
Step Type
Value
Revenue
adjust
$65.27M
Cost of Goods Sold
adjust
$-57.38M
Gross Profit
subtotal
$7.90M
SG&A
adjust
$-22.40M
R&D
adjust
$-519.36K
Other Operating Expense
adjust
$-1.52M
Operating Income
subtotal
$-16.54M
Other / Non-Operating Items
adjust
$-2.60M
Net Income
subtotal
$-19.14M

Earnings Per Share (EPS) History

▼

Financial Ratios

▼

📦 Raw API Data (JSON Explorer)

▼

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about COSM.US!